Methenmadinone acetate

ADVERTISEMENT

Identification

Molecular formula
C16H28NO2
CAS Number
83426-05-3
IUPAC Name
N-methyl-N-[(3-methylnorbornan-2-yl)methyl]butanamide
Molecular Weight
256.41g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
0.9453g/cm3
Synonyms
18966-37-5
Interesting facts

Exploring N-methyl-N-[(3-methylnorbornan-2-yl)methyl]butanamide

N-methyl-N-[(3-methylnorbornan-2-yl)methyl]butanamide, a fascinating compound, showcases the intricate world of amides and their derivatives. This compound is particularly interesting due to its unique structural characteristics, which contribute to its potential applications in various fields.

Key Insights

  • Synthetic Chemistry: The synthesis of N-methyl-N-[(3-methylnorbornan-2-yl)methyl]butanamide highlights essential techniques in organic chemistry, showcasing methods such as alkylation and amide formation, crucial for the development of pharmaceutical compounds.
  • Biological Activity: Many compounds similar to this structure exhibit significant biological activities, including potential analgesic and anti-inflammatory effects, making them valuable in drug discovery.
  • Structure-Activity Relationship (SAR): The presence of the norbornane moiety may influence the compound's interaction with biological targets, underscoring the importance of SAR studies in medicinal chemistry.
  • Chirality: This compound has chiral centers, which could lead to enantiomeric variations that might exhibit different biological properties, further emphasizing the need for careful characterization in research.

β€œIn chemistry, the complexities of a single compound can lead to vast possibilities in application and understanding.”

Researchers continue to explore such compounds not only for their immediate effects but also for how slight modifications in structure can lead to enhanced efficacy or reduced side effects. The ongoing study of N-methyl-N-[(3-methylnorbornan-2-yl)methyl]butanamide exemplifies the larger narrative of chemical innovation and the pursuit of new therapeutic agents.

ADVERTISEMENT